Safety · Capsular Contracture
Capsular contracture
Thickening and tightening of the scar tissue capsule around breast implants. Modern incidence 2-6% over 10 years. Baker grade classification, modern surgical prevention, treatment options.
Clinical summary
Capsular contracture is thickening and tightening of the scar tissue capsule that normally forms around any breast implant. Modern incidence approximately 2-6% over 10 years depending on surface, placement, and surgical technique. Severity classified by Baker grades (I-IV); Grades III-IV require surgical revision. Modern surgical technique (antimicrobial irrigation, minimal handling, fast operation, smoking cessation) has reduced rates substantially vs historical data. Revision options include capsulectomy + new implant, with polyurethane-coated implants showing lowest recurrence rates.
What capsular contracture is
When any foreign object — including breast implants — is placed inside the body, the body forms a thin layer of scar tissue around it. This is normal, expected, and happens with all implants. The scar tissue capsule is part of normal healing.
Capsular contracture is when this normal scar tissue becomes:
- Thickened — the capsule becomes substantially thicker than the normal thin layer.
- Contracted — the capsule shrinks, squeezing the implant.
- Calcified in advanced cases — the capsule develops calcium deposits.
- Symptomatic — causes visible distortion, firmness, sometimes pain.
The implant itself is unchanged. The problem is the surrounding tissue, not the implant.
Baker grade classification
| Grade | Capsule | Appearance | Symptoms | Treatment |
|---|
| Baker I | Soft, normal capsule | Breast looks normal | None | None — normal finding |
| Baker II | Slightly firm capsule | Breast looks normal | Mild firmness on palpation | Observation; sometimes medications |
| Baker III | Firm capsule | Breast appears distorted | Visible distortion, palpable firmness | Surgical revision typically needed |
| Baker IV | Hard capsule | Breast clearly distorted | Pain, hardness, asymmetry | Surgical revision required |
The grading is clinical — assessed by physical examination, not imaging. Grade I is normal; Grade II is acceptable for most patients; Grades III and IV are problematic and typically warrant surgical revision.
What causes contracture
The exact mechanism is not fully understood. Major contributing factors:
Subclinical bacterial biofilm
The leading current theory. Low-grade bacterial colonization of the implant surface during placement (from skin flora, surgical environment, breast tissue itself) triggers chronic low-grade immune response. Modern antimicrobial irrigation (typically Betadine or triple-antibiotic solution) and minimal-handling technique reduce bacterial exposure.
Hematoma or seroma
Blood collection (hematoma) or fluid collection (seroma) around the implant during healing increases contracture risk. Modern technique (careful hemostasis, drain placement when indicated, smaller pocket dimensions) reduces these collections.
Implant surface characteristics
Historical data showed macrotextured implants had lowest contracture rates; modern data shows the difference between surfaces is smaller than historically thought. Polyurethane-coated implants (Polytech) have the lowest documented rates.
Patient factors
- Smoking — increases contracture risk substantially. Cessation 4-6 weeks pre-op and post-op recommended.
- Radiation therapy — substantially increases contracture risk in reconstruction patients.
- Certain medications — some chemotherapy agents and immunosuppressants.
- Prior breast surgery — patients with prior contracture have higher recurrence risk.
Surgical technique
- Antimicrobial irrigation of pocket before implant placement.
- Minimal handling of implant during placement.
- Sterile field discipline — Keller funnel use, no-touch technique.
- Fast operation — shorter operative time reduces bacterial exposure.
- Pocket size matching implant dimensions.
Modern incidence rates
| Surface / placement | 10-year contracture rate (modern) |
|---|
| Smooth surface, subglandular | ~5-7% |
| Smooth surface, submuscular/dual-plane | ~3-5% |
| Microtextured, subglandular | ~3-5% |
| Microtextured, submuscular/dual-plane | ~2-4% |
| Polyurethane-coated | ~1-2% |
| After capsular contracture revision (standard) | ~25-30% recurrence |
| After revision with polyurethane | ~5-10% recurrence |
Modern rates are substantially lower than historical data (10-15% in older series). The improvement reflects better surgical technique, modern shell technology, antimicrobial protocols, and patient factor optimization.
How contracture is prevented
Modern surgical practice combines multiple risk reduction measures:
- Sterile field discipline — strict antimicrobial protocols throughout operation.
- Antimicrobial irrigation — pocket irrigated with Betadine or triple-antibiotic solution before implant placement.
- Keller funnel — no-touch implant insertion device that minimizes contact with skin and tissue.
- Minimal handling of implant during placement.
- Atraumatic dissection — clean pocket creation with minimal bleeding.
- Pocket size matching implant dimensions.
- Smoking cessation — 4-6 weeks pre-op and post-op minimum.
- Patient education — early reporting of any concerning symptoms.
Treatment options
| Option | Description | Indication |
|---|
| Observation + medications | Singulair (leukotriene inhibitor), anti-inflammatories | Baker II asymptomatic |
| Capsulotomy | Capsule cut/released without removal | Mild contracture; less reliable |
| Capsulectomy + new implant | Capsule removed, fresh implant | Standard treatment for Baker III-IV |
| Plane change | Subglandular → submuscular/dual-plane | Adjunct to capsulectomy |
| Polyurethane-coated implant | Replace with polyurethane surface | Lowest recurrence rate |
| Acellular dermal matrix (ADM) | Tissue reinforcement | Adjunct in complex revision |
| Implant removal without replacement | Explant only | Patient choice; multiple recurrences |
The right treatment depends on grade severity, patient priorities, and clinical findings. Most Baker III-IV cases benefit from capsulectomy + new implant. For patients with multiple recurrences or strong polyurethane-coated availability, the surface change is often added. See implant exchange page for revision details and polyurethane-coated implants for surface alternative.
Frequently asked questions
What is capsular contracture?
Every breast implant develops a thin scar tissue capsule around it as the body's normal response — this is normal and expected. Capsular contracture is when this scar tissue becomes thickened, contracted, and tight, squeezing the implant. The implant itself is unchanged; the surrounding tissue is the problem. Symptoms range from mild firmness (Baker grade I) to visible distortion and pain (Baker grade IV). Modern incidence approximately 2-6% over 10 years depending on surface, placement, and surgical technique.
What causes capsular contracture?
The exact mechanism is not fully understood. Major theories: (1) Subclinical bacterial biofilm — low-grade bacterial colonization of the implant surface triggering chronic immune response. (2) Hematoma or seroma — blood or fluid collection around implant during healing. (3) Implant surface characteristics — historical macrotextured had lowest rates; modern shifts complex. (4) Patient factors — smoking, radiation therapy, certain medications. (5) Surgical technique — sterility, atraumatic dissection, minimal handling. Modern surgical practice (sterile field, antimicrobial irrigation, minimal handling, fast operation) reduces contracture rates substantially.
What are Baker grades?
Standard classification of capsular contracture severity. Grade I: capsule present but normal — soft, no visible problem. Grade II: capsule slightly firm but breast appears normal. Grade III: capsule firm, breast appears distorted (visibly different shape). Grade IV: capsule hard, breast distorted, painful. Grades I-II are considered normal/acceptable; Grades III-IV are clinical contracture requiring treatment. The grading is clinical (assessed by examination), not imaging.
How is capsular contracture treated?
Mild (Baker II): observation and monitoring; sometimes anti-inflammatory medications, leukotriene inhibitors (Singulair). Symptomatic Grade III/IV: surgical revision typically needed. Surgical options: (1) Capsulectomy (capsule removal) + new implant — most reliable treatment. (2) Capsulotomy (capsule cut to release) — less reliable, higher recurrence. (3) Acellular dermal matrix (ADM) reinforcement — adjunct in revision. (4) Surface change — switching to polyurethane-coated implants reduces recurrence. (5) Plane change — moving from subglandular to submuscular if not already done.
Can capsular contracture be prevented?
Risk reduced by: modern surgical technique (antimicrobial irrigation, minimal handling, sterile field discipline, fast operation), patient factors (smoking cessation 4-6 weeks pre-op and post-op), implant surface and placement matched to anatomy (dual-plane vs subglandular based on tissue thickness), avoiding radiation therapy when possible, prompt treatment of any infection. Modern practice has reduced contracture rates substantially compared to historical data — modern rates 2-6% over 10 years vs 10-15% in older series.
What's the recurrence rate after revision?
Higher than first-time contracture rate but improving with modern techniques. Standard implant + capsulectomy: ~25-30% recurrence over 10 years. Polyurethane-coated implant + capsulectomy: ~5-10% recurrence. Plane change (subglandular to submuscular) + capsulectomy: lower recurrence. ADM reinforcement: lower recurrence in some series. The combination of technique + polyurethane coating + plane optimization produces the lowest recurrence rates in modern revision practice. Capsulectomy alone without these adjuncts has highest recurrence.
Related references